
-
Immuneering Corporation NASDAQ:IMRX
Location: | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing
Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
14.31M
Cash
36.14M
Avg Qtr Burn
-13.75M
Short % of Float
3.92%
Insider Ownership
24.07%
Institutional Own.
12.07%
Qtr Updated
12/31/24
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
IMM-1-104 Details Solid tumor/s, Cancer, Pancreatic cancer | Phase 2a Data readout | |
IMM-1-104 + G12C inhibitor Details Cancer, Non-small cell lung carcinoma | Phase 2a Initiation | |
IMM-1-104 + Libtayo Details Cancer, Non-small cell lung carcinoma | Phase 2a Initiation | |
IMM-1-104 + PD-1 inhibitor Details Cancer, Melanoma | Phase 2a Initiation | |
IMM-1-104 + BRAF inhibitor Details Cancer, Melanoma | Phase 2a Initiation | |
IMM-6-415 Details Solid tumor/s | Phase 1/2 Data readout |